5.29
Schlusskurs vom Vortag:
$4.96
Offen:
$4.94
24-Stunden-Volumen:
286.85K
Relative Volume:
2.75
Marktkapitalisierung:
$358.91M
Einnahmen:
$64.49M
Nettoeinkommen (Verlust:
$-71.40M
KGV:
-4.8532
EPS:
-1.09
Netto-Cashflow:
$-52.00M
1W Leistung:
+13.28%
1M Leistung:
+15.00%
6M Leistung:
+42.97%
1J Leistung:
+82.41%
Sophia Genetics Sa Stock (SOPH) Company Profile
Firmenname
Sophia Genetics Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SOPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SOPH
Sophia Genetics Sa
|
5.29 | 336.52M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
240.12 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.27 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.79 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.15 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.53 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-18 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-03 | Eingeleitet | BTIG Research | Buy |
| 2022-11-23 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-17 | Eingeleitet | JP Morgan | Overweight |
| 2021-08-17 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten
Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleJuly 2025 Action & Growth Oriented Trade Recommendations - ulpravda.ru
Will SOPHiA GENETICS SA stock maintain dividend yieldMarket Sentiment Review & Daily Risk Controlled Trade Plans - ulpravda.ru
Why SOPHiA GENETICS SA stock remains on buy listsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - ulpravda.ru
Why analysts recommend SOPHiA GENETICS SA (90B) stock2025 Valuation Update & Weekly Watchlist for Consistent Profits - ulpravda.ru
Published on: 2026-01-09 00:00:10 - ulpravda.ru
Will SOPHiA GENETICS SA (90B) stock outperform global peersJuly 2025 Market Mood & High Accuracy Trade Alerts - ulpravda.ru
Is SOPHiA GENETICS SA stock ready for breakoutQuarterly Market Summary & Free Safe Entry Trade Signal Reports - ulpravda.ru
Income Plays: Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleWeekly Investment Recap & High Return Stock Watch Alerts - ulpravda.ru
Aug Sectors: Is SOPHiA GENETICS SA stock ready for breakoutWeekly Trade Analysis & Long Hold Capital Preservation Tips - moha.gov.vn
How SOPHiA GENETICS SA stock benefits from global expansionStock Rotation Strategies & Access Free Risk Analysis Before You Invest - ulpravda.ru
Tech Rally: Will SOPHiA GENETICS SA 90B stock outperform global peers2025 Market Outlook & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Sophia Genetics stock rises on MD Anderson Cancer Center partnership - Investing.com
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology - Finviz
SOPHiA GENETICS and MD Anderson partner on AI-driven cancer care - Investing.com UK
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and Clover Health Investments (NASDAQ:CLOV) - Defense World
Will SOPHiA GENETICS SA stock benefit from upcoming earnings reports2026 world cup usa national team semifinals star players low block defense group prediction expert opinion - ulpravda.ru
Can Nirlon Limited (500307) Maintain Its ValuationMarket Capitalization Trends & Our Picks = Your Future Gains - bollywoodhelpline.com
RSI Reset May Fuel Rebound in Sanstar LimitedMerger & Acquisition Updates & Outperform With Our Smart Trading Calculator - bollywoodhelpline.com
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), UCB SA (GB:0NZT) and Cibus (CBUS) - The Globe and Mail
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - Defense World
SOPHiA GENETICS (NASDAQ:SOPH) Within Nasdaq Futures Focus - Kalkine Media
Reviving an old journey post retirementTrading Volume Surges & Build a Dividend-Powered Portfolio - bollywoodhelpline.com
SOPHiA GENETICS (NASDAQ:SOPH) Trading 2.8% HigherWhat's Next? - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Trading 2.8% Higher – What’s Next? - Defense World
Mukta Agriculture Limited Hits Oversold Level on RSI IndicatorHealthcare Stock Analysis & Real-Life Case Studies You Can Follow - bollywoodhelpline.com
Aug Chart Watch: Is SOPHiA GENETICS SA stock a buy before product launchesRisk Management & Stepwise Swing Trade Plans - moha.gov.vn
Swiss stocksFactors to watch on December 23 - MarketScreener
A activityMarket Sentiment Report & Trade Opportunity Analysis Reports - Улправда
What is the fair value of SOPHiA GENETICS SA stock nowQuarterly Risk Review & Real-Time Volume Analysis Alerts - Улправда
Why SOPHiA GENETICS SA (90B) stock remains stableRecession Risk & Reliable Breakout Stock Forecasts - Улправда
What makes SOPHiA GENETICS SA stock attractive to growth fundsJuly 2025 Breakouts & Low Drawdown Investment Strategies - Улправда
VP Menu Files To Sell 608 Of SOPHiA GENETICS SA [SOPH] - TradingView — Track All Markets
Will SOPHiA GENETICS SA stock gain from government policies2025 Key Lessons & Real-Time Buy Signal Notifications - Улправда
Will SOPHiA GENETICS SA (90B) stock profit from fiscal stimulusPortfolio Performance Report & Safe Swing Trade Setup Alerts - DonanımHaber
Will SOPHiA GENETICS SA stock maintain momentum in 2025Weekly Trend Summary & Long-Term Capital Growth Strategies - Улправда
Can SOPHiA GENETICS SA stock maintain growth trajectoryPortfolio Performance Report & Expert Curated Trade Setup Alerts - Улправда
Can SOPHiA GENETICS SA (90B) stock beat analyst consensus2025 Stock Rankings & Verified Momentum Stock Ideas - DonanımHaber
Is SOPHiA GENETICS SA stock a buy before product launches2025 Earnings Impact & Growth Oriented Trading Recommendations - DonanımHaber
Can SOPHiA GENETICS SA stock beat market expectations this quarterGold Moves & Weekly Breakout Watchlists - Улправда
Is SOPHiA GENETICS SA (90B) stock worth holding before Fed meetingMarket Sentiment Summary & Stock Timing and Entry Methods - Улправда
Will FinWise Bancorp stock attract ESG investorsJuly 2025 Price Swings & Real-Time Volume Spike Alerts - Улправда
Oncology Biotech Challenges Rival's Cancer Testing Patent - Law360
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave - Cantech Letter
Precision Medicine Software Market to Hit USD 5.25 Billion - openPR.com
What analysts say about SOPHiA GENETICS SA stockTechnical Resistance Breaks & Exceptional Trading Strategies - earlytimes.in
Comparing SOPHiA GENETICS (NASDAQ:SOPH) and Azenta (NASDAQ:AZTA) - Defense World
Performance Recap: What is the fair value of SOPHiA GENETICS SA stock now2025 Technical Overview & Stepwise Entry and Exit Trade Signals - moha.gov.vn
321,527 Shares in SOPHiA GENETICS SA $SOPH Purchased by Archon Capital Management LLC - MarketBeat
SOPHiA GENETICS : Tyrolpath Adopts MSK-IMPACT®-Flex powered with SOPHiA DDM™ to Expand Precision Oncology in Austria - marketscreener.com
Is SOPHiA GENETICS SA (90B) stock vulnerable to rate hikesQuarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Can SOPHiA GENETICS SA stock sustain free cash flow growthWeekly Trend Recap & Real-Time Buy Signal Alerts - Newser
Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):